Bonus Shares in December 2022

Explore

Tarsons Products IPO

Incorporated in 1983, Tarsons Products Ltd. is one of the leading life sciences companies involved in the manufacturing and supplying of labware products. The company comes with a highly diversified product portfolio, including lab consumables, reusable products and more.

Products manufactured in Tarsons are widely used across hospitals, diagnostic labs, academic institutions, pharmaceutical companies and more.

Tarsons Products currently has 5 manufacturing facilities in West Bengal, sprawling over 20,000 square metres. As of 31 March 2021, the company has a product portfolio with more than 1,700 SKUs for 300 products. 

The company has a robust distribution network throughout India, with more than 141 authorised distributors. Moreover, it supplies its products to more than 40 countries. 

Tarsons Products IPO: Objectives

Tarsons Products intends to use the proceeds from its public offering for the following purposes:

  • To fund a portion of the capital expenditure that is required for the expansion of its facility in Panchla, West Bengal
  • To either repay or prepay its borrowings 
  • For general corporate expenses

Tarsons Products IPO - Details

Tarsons Products filed its DRHP with market regulator SEBI for its IPO on 10 August 2021. The initial public offering of Tarsons Products will include a fresh issuance of shares worth Rs. 150 crores and an offer for sale of 1.32 crores shares by the existing investors and promoters. 

The offer for sale will include the offloading of 3.9 lakhs shares by Sanjive Sehgal, and 3.1 lakhs share sale by Rohan Sehgal. Apart from this, Clear Vision Investment Holdings Pvt. Ltd. is set to release around 1.25 crores shares. Tarsons Products IPO will also include a reservation for company employees. 

The key details of Tarsons Products IPO are shown in the following tabular representation:

Opening Date

Nov 15, 2021

Closing Date

Nov 17, 2021

Price Band

₹635 to ₹662

per equity share

Issue Size

₹1,023.47 Cr

Face Value

₹ 2

per equity share

Market Lot

22 Shares

Opening Date

Sep 14, 2021

Closing Date

Sep 16, 2021

Price Band

₹734 to ₹744

per equity share

Issue Size

₹1265 - ₹1283 Cr

Face Value

₹ 2

per equity share

Market Lot

20 Shares

Listing at NSE, BSE

Tarsons Products IPO Important Dates

IPO Open Date 15 November 2021
IPO Close Date 17 November 2021
Date for Basis of Allotment 23 November 2021
Initiation Of Refunds 24 November 2021
Credit Of Shares To
Demat ACcount
26 November 2021

Tarsons Products IPO Latest News and Subscription Status Today [Live]

At 10.40:00 AM.

- This IPO has been subscribed 4.18x by 10:40 AM. on Day 3

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 1.30x

- (NII) Non-institutional buyers: 4.69x

- (RII) Retail Individual buyers: 5.63x

-Employees: 1.15x 



At 11.40:00 AM.

- This IPO has been subscribed 4.80x by 11:40 AM. on Day 3

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 1.32x

- (NII) Non-institutional buyers: 5.58x

- (RII) Retail Individual buyers: 6.50x

-Employees: 1.21x 



At 12.40:00 PM.

- This IPO has been subscribed 8.06x by 12:40 PM. on Day 3

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 1.49x

- (NII) Non-institutional buyers: 19.07x

- (RII) Retail Individual buyers: 7.17x

-Employees: 1.27x

At 10.40:00 AM.

- This IPO has been subscribed 1.38x by 10:40 AM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.21x

- (RII) Retail Individual buyers: 2.69x

- Employees: 0.48x 

 

At 11.40:00 AM.

- This IPO has been subscribed 1.53x by 11:40 AM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.21x

- (RII) Retail Individual buyers: 2.95x

- Employees: 0.64x 

 

At 12.40:00 PM.

- This IPO has been subscribed 1.66x by 12:40 PM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.21x

- (RII) Retail Individual buyers: 3.23x

- Employees: 0.65x 

 

At 1.40:00 PM.

- This IPO has been subscribed 1.77x by 1:40 PM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.28x

- (RII) Retail Individual buyers: 3.42x

- Employees: 0.67x 

 

At 2.40:00 PM.

- This IPO has been subscribed 2.08x by 2:40 PM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 0.24x

- (NII) Non-institutional buyers: 0.38x

- (RII) Retail Individual buyers: 3.87x

- Employees: 0.90x 



At 3.40:00 PM.

- This IPO has been subscribed 3.18x by 3:40 PM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 1.10x

- (NII) Non-institutional buyers: 3.69x

- (RII) Retail Individual buyers: 4.18x

- Employees: 0.90x 

 

At 5.05:00 PM.

- This IPO has been subscribed 3.58x by 5:05 PM. on Day 2

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 1.30x

- (NII) Non-institutional buyers: 3.98x

- (RII) Retail Individual buyers: 4.74x

- Employees: 1.08x

At 11.00:00 AM.

- This IPO has been subscribed 0.33x by 11:00 AM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.01x

- (RII) Retail Individual buyers: 0.67x

- Employees: 0.00x 



At 12.05:00 PM.

- This IPO has been subscribed 0.48x by 12:05 PM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.01x

- (RII) Retail Individual buyers: 0.96x

- Employees: 0.04x 



At 1.05:00 PM.

- This IPO has been subscribed 0.60x by 1:05 PM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.05x

- (RII) Retail Individual buyers: 1.18x

- Employees: 0.07x 

 

At 2.05:00 PM.

- This IPO has been subscribed 0.71x by 2:05 PM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.06x

- (RII) Retail Individual buyers: 0.15x

- Employees: 0.07x 

 

At 3.05:00 PM.

- This IPO has been subscribed 0.84x by 3:05 PM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.09x

- (RII) Retail Individual buyers: 1.65x

- Employees: 0.19x 

 

At 4.05:00 PM.

- This IPO has been subscribed 0.93x by 4:05 PM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.10x

- (RII) Retail Individual buyers: 1.82x

- Employees: 0.29x 



At 5.05:00 PM.

- This IPO has been subscribed 1.09x by 5:05 PM. on Day 1

- It is a public issue of 1,08,44,104 equity shares.

 Status of Subscription

- (QIB) Qualified institutional buyers: 0.00x

- (NII) Non-institutional buyers: 0.17x

- (RII) Retail Individual buyers: 2.12x

- Employees: 0.41x

Why Should You Invest in Tarsons Products IPO?

Here are some of the key reasons why Tarsons Products is an ideal investment option: –

  1. Tarsons Products is one of the top life sciences companies engaged in manufacturing a wide range of lab components. The company is known for its high-quality goods and excellent brand awareness.
  2. The company comes with a massive client base, including some of the reputed Indian institutions such as Dr. Reddy’s Laboratories, Indian Institute of Chemical Technology, Metropolis Healthcare, Dr. Lal Path Labs, Enzene Biosciences, National Centre for Biological Sciences, and more.
  3. Tarsons Products has a robust sales and distribution network across the country. It also supplies its products to major international markets.
  4. The company comes with impressive financials with strong assets, revenue generation and profit.

Financial Highlights

Financial Year Total Assets Total Revenue Profit After Tax
30 June 2021 Rs. 3,647.74 Rs. 711.27 Rs. 248.35
31 March 2021 Rs. 2,959.50 Rs. 2,342.91 Rs. 688.70
30 June 2020 Rs. 2,356.57 Rs. 435.73 Rs. 69.68
31 March 2020 Rs. 2,487.06 Rs. 1,800.54 Rs. 405.31
31 March 2019 Rs. 2,119.58 Rs. 1,847.19 Rs. 389.58
**Note: Amount is in millions

How to Apply for Tarsons Products IPO?

You can apply for the Tarsons Products IPO in these ways:

Demat Account

1. The existing users of the Angel One platform can click here to apply for Tarsons Products IPO.
2. However, new investors can open a Demat account free of cost on the Angel One platform. Then, investors can log in with the credentials that they receive to start bidding for Tarsons Products IPO.

UPI
Alternatively, you can apply for Tarsons Products IPO through UPI. First, you need to connect your bank account with a preferred UPI platform. Then, link it with your Angel One account. After that, you can use the UPI option present on the Angel One website and app to subscribe to Tarsons Products IPO.
Finally, go to the UPI app to book shares for the IPO.

Tarsons Products IPO – Noteworthy Highlights

The following section consists of some crucial highlights about Tarsons Products that prospective investors should be aware of:

1. The company boasts of having 5 well-equipped manufacturing facilities that are vertically integrated and come with automation facilities. This helps the company to maintain quality while cutting costs.

2. For the financial year ending on 31 March 2021, Tarsons Products registered a 23.67% growth in its net worth along with a 49.36% jump in EBITDA.

3. The total asset of Tarsons Products climbed by 19% during the last financial year.

4. Some of its products, such as cryovials, macro tips, micro tips, and centrifuge tubes, have received CE-IVD certification.

5. The company exports its lab products to more than 40 countries.

6. Tarsons Products come with operating revenue that ranges between Rs. 100-Rs. 500 crores for the financial year that ended on 31 March 2021.

Tarsons Products IPO - SWOT Analysis

strengths

Strengths

  • Diverse product portfolio: Tarsons Products manufactures and supplies a diverse range of labware components which are broadly classified into consumables, reusable and other products.

    The consumable product section includes cryogenic ware, petri dish, PCR consumables transfer pipettes and more. In the reusable segments, the company manufactures bottles, beakers, carboys and more. It also produces vortex shakers, centrifuges and other benchtop instruments. These products are supplied to numerous reputed hospitals, diagnostic centres and national institutions.
  • Addresses a Large Market: The labware market is witnessing massive growth in India fueled by increased investment, growing awareness for health issues, and enormous growth in the health sector. Tarsons addresses a major domestic and international market and maintains long-term connections with its customers and clients.
  • Strong Management Team: Founded in 1983, Tarsons Products is backed by highly experienced promoters and a powerful management team. This has enabled the company to bolster its presence in the Indian labware market.
  • Strong Financial Performance: Tarsons has been able to post improved financial performance due to cost-cutting and higher profitability. The company's revenue and profit have been on a steady rise for the past three years. Its long-term and current borrowings have also come down recently.
Weaknesses

Weaknesses

  • Cost Overrun or Implementation Delay: The company has five facilities and is planning to build another one. Moreover, it would be working on expanding all the existing facilities. Considering the capacity of the expansion plan, Tarsons might be facing implementation delays or cost overruns.
  • Geographical Concentration of Manufacturing Units: All of the manufacturing units of Tarsons Products are located in West Bengal. Around 86.32% of the manufacturing revenue comes from the units located at Dhulagarh and Jangalpur. Such concentration of manufacturing might affect business operations and finances.
  • Pending Land Approval at one of the Facilities: The manufacturing facility at Jangalpur is situated on a plot for which the company is yet to receive complete approval. Delay in approval might lead to regulatory actions in the future.
Opportunities

Opportunities

  • Expansion of Client Base: The healthcare sector of the country will see significant growth as investments are set to increase. Consequently, the demand for lab consumables and reusable products would jump, leading to a potential expansion of the labware market. Tarsons already has an impressive list of reputed clients. However, it has the potential to expand its client base with rising demand.
Threats

Threats

  • Rise in Inflation: Inflation rates have been quite volatile in recent years. If inflation rises in the upcoming days, it will lead to increased expenses and reduced revenue generation. This can adversely impact the business prospects and finances of the company.
  • Impact of the Pandemic: Although the COVID-19 pandemic has subdued in recent months, the threat still remains. The new virus variants might spark off COVID-19 waves, which can significantly affect the business.
Strenghts Strengths
Weaknesses Weaknesses
Opportunities Opportunities
Threats Threats

Strengths

  • Diverse Product Portfolio: Tarsons Products manufactures and supplies a diverse range of labware components which are broadly classified into consumables, reusable and other products.
    The consumable product section includes cryogenic ware, petri dish, PCR consumables transfer pipettes and more. In the reusable segments, the company manufactures bottles, beakers, carboys and more. It also produces vortex shakers, centrifuges and other benchtop instruments. These products are supplied to numerous reputed hospitals, diagnostic centres and national institutions.
  • Addresses a Large Market: The labware market is witnessing massive growth in India fueled by increased investment, growing awareness for health issues, and enormous growth in the health sector. Tarsons addresses a major domestic and international market and maintains long-term connections with its customers and clients.
  • Strong Management Team: Founded in 1983, Tarsons Products is backed by highly experienced promoters and a powerful management team. This has enabled the company to bolster its presence in the Indian labware market.
  • Strong Financial Performance: Tarsons has been able to post improved financial performance due to cost-cutting and higher profitability. The company's revenue and profit have been on a steady rise for the past three years. Its long-term and current borrowings have also come down recently.

Weaknesses

  • Cost Overrun or Implementation Delay: The company has five facilities and is planning to build another one. Moreover, it would be working on expanding all the existing facilities. Considering the capacity of the expansion plan, Tarsons might be facing implementation delays or cost overruns.
  • Geographical Concentration of Manufacturing Units: All of the manufacturing units of Tarsons Products are located in West Bengal. Around 86.32% of the manufacturing revenue comes from the units located at Dhulagarh and Jangalpur. Such concentration of manufacturing might affect business operations and finances.
  • Pending Land Approval at one of the Facilities: The manufacturing facility at Jangalpur is situated on a plot for which the company is yet to receive complete approval. Delay in approval might lead to regulatory actions in the future.

Opportunities

  • Expansion of Client Base: The healthcare sector of the country will see significant growth as investments are set to increase. Consequently, the demand for lab consumables and reusable products would jump, leading to a potential expansion of the labware market. Tarsons already has an impressive list of reputed clients. However, it has the potential to expand its client base with rising demand.

Threats

  • Rise in Inflation: Inflation rates have been quite volatile in recent years. If inflation rises in the upcoming days, it will lead to increased expenses and reduced revenue generation. This can adversely impact the business prospects and finances of the company.
  • Impact of the Pandemic: Although the COVID-19 pandemic has subdued in recent months, the threat still remains. The new virus variants might spark off COVID-19 waves, which can significantly affect the business.

Competitor Analysis: Tarsons Products

Tarsons Products is one of the most notable labware manufacturers in the country, with presence in over 40 countries. Here is a brief overview of some of the prominent competitors of Tarsons Products:

Competitor Revenue
Innova Corporate $17 million
Acumen Labware $5 million
BrandTech Scientific Inc. $5-$9.9 million
PlastX $5 million
Jensen Inert Products $1- $4.9 million

Tarsons Products IPO FAQs

How can I apply for Tarsons Products IPO with the Angel One app?

You can apply for an IPO on the Angel One app through these steps:
Step 1: First, open the Angel One app and click on ‘Investment Opportunities'.
Step 2: Now, tap on ‘IPOs and FPOs’ and provide the necessary data.
Step 3: Put the valid UPI ID as authenticated by NPCI.
Step 4: Click on ‘Invest’ to subscribe to Tarsons Products IPO.

I don’t have a UPI ID. Can I apply for Tarsons Products IPO?

If you don’t have a UPI ID, you can use the ASBA process from your bank account to subscribe to Tarsons Products IPO. However, you can easily create a UPI handle from the NPCI list to apply with a UPI ID.

How can I locate my UPI ID?

Go to the ‘Profile’ section of your UPI app to locate your UPI ID. You can click here to check the screenshot for finding the UPI IDs on different apps. 

When is the UPI mandate request approved?

The time period within which you will likely receive the approval for your UPI mandate request is from the closing time of the IPO till 12 PM the next day.

How to create a UPI ID with the BHIM app?

Here is a step-by-step guide to creating a UPI ID on the BHIM app:

Step 1: Download the BHIM app.

Step 2: Now, verify the mobile number and then register using a password. 

Step 3: Select your bank from the provided list.

Step 4: BHIM app will fetch your bank account details automatically.

Step 5: If you have more than one bank account, choose the one that you want to register with.

Step 6: Set a personal UPI ID.

Once done, you can check your UPI ID from the ‘Profile’ section.

Can I opt for multiple applications for Tarsons Products IPO?

No, you are not allowed to file for one application for one PAN number. Nonetheless, if you try to file for more than one application using the same PAN using different platforms, your applications will be rejected.

How soon can I expect the UPI mandate request after placing an order?

You can expect to receive a UPI mandate request around 15 to 20 minutes after putting in the bid. However, you can face delays at times.

Why am I not able to apply for Tarsons Products IPO through UPI ID?

You have to use NPCI-approved UPI IDs while applying for Tarsons Products IPO. If you are facing any issue with your UPI ID, make sure to check the list of banks that are approved by NPCI to provide UPI services

Can I apply for Tarsons Products IPO if I don’t have my bank account linked with Angel One?

Yes, you can, but the bank account has to be in your name.

Why am I not able to find my UPI handle from the Angel One dropdown menu?

If you cannot find your UPI ID in the dropdown list of the Angel One app, it would imply that NPCI has not approved the ID. Make sure to create a UPI ID with a financial body that is on the list of NCPI.

Do I have to pay a fee to apply for Tarsons Products IPO?

You are not required to pay an additional charge if you apply for Tarsons Products IPO via the Angel One platform.

What is the cut-off price? Can I apply at this price?

Cut-off price is the rate at which the shares for Tarsons Products IPO will be issued. It is fixed during the allotment process, and when one applies at this price, it would mean that they would be bidding at the said price point.
Bidders should apply at the cut-off price to increase their chances of share allotment. 

Can I apply for Tarsons Products IPO with a current account?

No. Your application for Tarsons Products IPO will be approved only with a savings account. Make sure to contact your bank to know more about this.

Can I apply for Tarsons Products IPO with my Hindu Undivided Family account?

You cannot apply for the IPO with a HUF account on the Angel One app. However, you can use it to apply through the ASBA process.

The status of the IPO mandate request is pending even after I have the mandate request approved. Why so?

The Angel One UPI mandate request is usually not updated on a real-time basis. In case your mandate is approved, it will be reflected in the order book of the IPO that you have applied for.

Can I apply for Tarsons Products IPO if I reside outside India?

If you are an NRI, you cannot apply for IPOs using the Angel One platform. However, you can subscribe for Indian IPOs through the ASBA of your bank. Make sure to contact your bank for more information.

What can lead to the rejection of my application for Tarsons Products IPO?

Your application for the IPO can be rejected for any of the following reasons:
  • You have provided an incorrect UPI ID during mandate approval.
  • The UPI ID, bank account and Demat account are not linked with the same PAN card.

Let’s take an instance to have a clear understanding. If you have used your Demat account along with the UPI ID of your friend while applying for Tarsons Products IPO, the application might get dismissed. This will happen because:

  • Your Demat account is not linked with your friend’s bank account.
  • Your PAN card is not connected with your friend’s UPI ID.

How much time is required to block or unblock funds for IPO subscription?

The funds for the Tarsons Products IPO will be blocked once you have approved the UPI mandate request. However, if you are not successful in securing shares during the IPO allotment or if the UPI mandate is no longer valid, then the amount will be unblocked. 

If the funds are not unblocked even after the aforementioned scenarios, you can contact your bank.

Can I subscribe to Tarsons Products IPO with my minor daughter’s account?

You are not allowed to apply for an IPO with your minor daughter’s account through the Angel One platform. Alternatively, you can apply through ASBA.

I have submitted my bids for Tarsons Products IPO. When will the funds be debited?

Financial institutions will not deduct the fund as soon as you apply for the Tarsons Products IPO. Banks will simply hold or block the amount. If you receive the allotment, the blocked amount will be deducted. On the contrary, if you are unable to secure share allotments, you will get back the amount before the UPI mandate expires.

How to secure share allotment without fail?

Allotment of IPO is not a guaranteed process. This is because, during the case of oversubscription, share allotment takes place through lottery. Bidders should be aware that Angel One is simply a platform that facilitates the application of IPOs. It has no role in the allotment. To ensure that your application receives successful allotment, you can:

  • Apply from one Demat account
  • Apply at the cut-off price
  • Make sure that your Demat account, UPI ID and bank account are linked with the same pan.

How can I delete or cancel my bid for Tarsons Products IPO?

Here’s how you can cancel or delete your bid for Tarsons Products IPO:

Step 1: Tap on the ‘Investment Opportunities’ option

Step 2: Go to ‘IPOs and FPOs’. 

Step 3: Click on ‘Order Book’ and choose the IPO that you wish to cancel or withdraw.

Step 4: Click on ‘Details’ and tap on the ‘Cancel’ option.

Your bid for the said IPO will be withdrawn.

Why did I fail to get an IPO allotment?

Non-allotment: Allotment takes place through a lottery in case of oversubscription.

Rejection: IPO application might be rejected if – 

  • One applies for IPO through various Demat accounts connected with the same PAN card.
  • The bid price is less than the final issue price. 
  • Demat account, bank account and UPI ID not linked with the one PAN card. 

Enjoy Zero Brokerage on
Equity Delivery

Enjoy Zero Brokerage on Equity Delivery

Get the link to download the App

Send App Link